Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Piccinino, E. Sagnelli, G. Pasquale, G. Giusti, A. Battocchia, M. Bernardi, R. Bertolazzi, F. Bianchi, E. Brunelli, G. Budillon, L. Buscarini, A. Cargnel, G. Carrara, N. Carulli, L. Caruso, V. Cataldi, G. Celle, L. Chiandussi, L. Chiesa, M. Colombo, M. Coltorti, C. Bac, C. Blanco, G. Marco, F. Fiaccadori, M. Filippazzo, F. Fornari, A. Francavilla, M. Frezza, V. Gallo, V. Galvani, T. Givatto, C. Iannuzzi, Izzo Cm, S. Moli, G. Longo, G. Magnani, M. Manai, F. Manenti, O. Manghisi, G. Manzillo, G. Marenco, F. Miglio, G. Molino, P. Mosca, R. Moschetta, C. Panella, G. Panichi, G. Parrilli, G. Pastore, Christopher Peluso, A. Picciotto, G. Pilleri, E. Pisi, M. Leon, M. Rago, G. Raimondo, G. Realdi, M. Rizzetto, A. Rizzo, G. Ronchi, F. Fanelli, G. Ruggiero, N. Russo, A. Satta, D. Sansonno, C. Struglia, P. Tolentino, F. Tremolada, C. Trischitta, G. Verme, P. Vigano, G. Visco, P. Zivelonghi (1986)
Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.Journal of hepatology, 2 2
Helen Lydatakis, Ieronymos Hager, E. Kostadelou, S. Mpousmpoulas, Stavros Pappas, I. Diamantis (2006)
Non‐invasive markers to predict the liver fibrosis in non‐alcoholic fatty liver diseaseLiver International, 26
M. Rinella, Richard McCarthy, K. Thakrar, J. Finn, Sambasiva Rao, A. Koffron, M. Abecassis, A. Blei (2003)
Dual‐echo, chemical shift gradient‐echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donationLiver Transplantation, 9
Se Kim, Jeong Lee, J. Han, Jae Lee, K. Lee, Chang Han, J. Jo, N. Yi, K. Suh, K. Shin, Soo Jo, B. Choi (2006)
Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings.Radiology, 240 1
E. Brunt (2001)
Nonalcoholic Steatohepatitis: Definition and PathologySEMINARS IN LIVER DISEASE,, 21
I. Guha, W. Rosenberg (2006)
Future use of the Glasgow alcoholic hepatitis score.Gut, 55 1
B Reid, Arun Sanyal (2004)
Evaluation and management of non-alcoholic steatohepatitis.European journal of gastroenterology & hepatology, 16 11
S. Saadeh, Z. Younossi, E. Remer, T. Gramlich, J. Ong, M. Hurley, K. Mullen, J. Cooper, M. Sheridan (2002)
The utility of radiological imaging in nonalcoholic fatty liver disease.Gastroenterology, 123 3
M. Fishbein, C. Potter, K. Gardner, P. Schmalbrock, Mark Smith (1995)
Introduction of fast MR imaging in the assessment of hepatic steatosis.Magnetic resonance imaging, 15 3
S. Locarnini (2004)
Molecular virology of hepatitis B virus.Seminars in liver disease, 24 Suppl 1
Xiaowei Zhang, M. Tengowski, L. Fasulo, S. Botts, S. Suddarth, G. Johnson (2004)
Measurement of fat/water ratios in rat liver using 3D three‐point dixon MRIMagnetic Resonance in Medicine, 51
J. Jacobs, B. Birnbaum, M. Shapiro, C. Langlotz, F. Slosman, S. Rubesin, S. Horii (1998)
Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT.AJR. American journal of roentgenology, 171 3
Charissa Chang, C. Argo, A. Al-Osaimi, S. Caldwell (2006)
Therapy of NAFLD: Antioxidants and Cytoprotective AgentsJournal of Clinical Gastroenterology, 40
E. Brunt, C. Janney, A. Bisceglie, B. Neuschwander‐Tetri, B. Bacon (1999)
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesionsAmerican Journal of Gastroenterology, 94
F. Pilleul, G. Chave, J. Dumortier, J. Scoazec, P. Valette (2005)
Fatty infiltration of the liver. Detection and grading using dual T1 gradient echo sequences on clinical MR system.Gastroenterologie clinique et biologique, 29 11
R. Johnston, E. Stamm, J. Lewin, R. Hendrick, P. Archer (1998)
Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurementsAbdominal Imaging, 23
C. Valls, Ricardo Iannacconne, E. Alba, T. Murakami, M. Hori, R. Passariello, V. Vilgrain (2006)
Fat in the liver: diagnosis and characterizationEuropean Radiology, 16
B. Mulhall, Z. Younossi (2004)
Nonalcoholic steatohepatitisCurrent Treatment Options in Gastroenterology, 7
S. Caldwell, C. Argo, A. Al-Osaimi (2006)
Therapy of NAFLD: insulin sensitizing agents.Journal of clinical gastroenterology, 40 Suppl 1
(2009)
Liver Steatosis Quantification Using MRI *
R. Longo, C. Ricci, F. Masutti, R. Vidimari, L. Crocè, L. Bercich, C. Tiribelli, L. Palma (1993)
Fatty Infiltration of the Liver: Quantification by 1H Localized Magnetic Resonance Spectroscopy and Comparison with Computed TomographyInvestigative Radiology, 28
E. Siegelman, M. Rosen (2001)
Imaging of Hepatic SteatosisSEMINARS IN LIVER DISEASE,, 21
T. Poynard, V. Ratziu, S. Naveau, D. Thabut, F. Charlotte, D. Messous, D. Capron, A. Abella, J. Massard, Y. Ngo, M. Munteanu, A. Mercadier, M. Manns, J. Albrecht (2005)
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosisComparative Hepatology, 4
A. Sanyal (2005)
Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver diseaseNature Clinical Practice Gastroenterology &Hepatology, 2
I. Guha, J. Parkes, P Roderick, S. Harris, W. Rosenberg (2006)
Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver diseaseGut, 55
M. Haque, A. Sanyal (2002)
The metabolic abnormalities associated with non-alcoholic fatty liver disease.Best practice & research. Clinical gastroenterology, 16 5
D. Kleiner, E. Brunt, M. Natta, Cynthia Behling, M. Contos, O. Cummings, L. Ferrell, Yao‐Chang Liu, M. Torbenson, A. Unalp-arida, M. Yeh, A. McCullough, A. Sanyal (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 41
C. Ricci, R. Longo, E. Gioulis, Marco Bosco, P. Pollesello, F. Masutti, L. Crocè, S. Paoletti, Benedetto Bernard, C. Tiribelli, L. Palma (1997)
Noninvasive in vivo quantitative assessment of fat content in human liver.Journal of hepatology, 27 1
M. Fishbein, S. Cheruku, Shaily Jain (2005)
Hepatic MRI for Fat Quantitation: Its Relationship to Fat Morphology, Diagnosis, and UltrasoundJournal of Clinical Gastroenterology, 39
ORIGINAL ARTICLE Liver Steatosis Quantification Using Magnetic Resonance Imaging: A Prospective Comparative Study With Liver Biopsy Nicolas Mennesson, MD,* Je´roˆme Dumortier, MD, PhD,Þ§ Vale´rie Hervieu, MD,þ§ Laurent Milot, MD,* Olivier Guillaud, MD,Þ Jean-Yves Scoazec, MD, PhD,þ§ and Frank Pilleul, PhD, MD*§ quired when an assessment of activity and severity of NAFLD Background and Aims: To prospectively determine the accuracy is considered necessary. of liver fat quantification with magnetic resonance imaging (MRI). In the United States, approximately 47 million individuals Patients and Methods: The population consisted of 40 patients 3 are estimated to have a metabolic syndrome : fatty infiltration (mean age, 52.5 years; range, 23Y78 years). The same day, all patients of the liver can be detected in up to 12% to 15% in this popula- underwent MRI and ultrasonography-guided liver biopsy. The histolog- 4 tion, and 3% to 4% of patients with NAFLD have steatohep- ical evaluation of steatosis was performed by an experienced liver atitis. Nonalcoholic steatohepatitis was originally believed to pathologist blinded to the MRI results. On T1-weighted in- and opposed- be a benign disease. However, it has been recently shown that phase images, one radiologist, experienced in abdominal imaging, 5 NASH could lead to irreversible
Journal of Computer Assisted Tomography – Wolters Kluwer Health
Published: Sep 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.